<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02368080</url>
  </required_header>
  <id_info>
    <org_study_id>StLuc MBWN2 01</org_study_id>
    <nct_id>NCT02368080</nct_id>
  </id_info>
  <brief_title>Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults</brief_title>
  <official_title>Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults: a Comparison of Two Commercially Available Devices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the lung clearance index (LCI) in cystic fibrosis and healthy adults
      obtained with two different multiple breath nitrogen washout (MBWN2) devices. Each
      participants will perform the test (LCI) in duplicate on each device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Using nitrogen as the inert gas, there are currently two commercially available devices that
      offer the possibility to measure the LCI. However, comparison between them are lacking. The 2
      MBWN2 devices are the &quot;EasyOne Pro Lab&quot; (ndd Medical Technologies, Zürich, Switzerland) and
      the &quot;Exhalyzer D&quot; (Eco Medics AG, Duernten, Switzerland).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lung Clearance Index (LCI)</measure>
    <time_frame>1 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Discriminative ability of LCI of each device (assessed by evaluating the proportion of patients with normal spirometry but high LCI with each device)</measure>
    <time_frame>1 hour</time_frame>
    <description>Difference in discriminative ability between devices will be assessed by evaluating the proportion of patients with normal spirometry but high LCI with each device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional residual capacity (FRC) ( the helium rebreathing technique (FRC He) with a &quot;Jaeger Masterscreen&quot; (Würzburg, Germany)</measure>
    <time_frame>1 hour</time_frame>
    <description>FRC will be compared with a third device in a subset of 11 healthy adults : the helium rebreathing technique (FRC He) with a &quot;Jaeger Masterscreen&quot; (Würzburg, Germany)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Subject's preference</measure>
    <time_frame>1 hour</time_frame>
    <description>Just after the completion of the tests, subjects will be asked to answer which one of the device they most preferred (i.e.: device A or device B or no preference).</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">95</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Cystic fibrosis adults (CF)</arm_group_label>
    <description>No treatment, comparison of LCI values obtained with two devices</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy adults (HC)</arm_group_label>
    <description>No treatment, comparison of LCI values obtained with two devices Free of respiratory disease or others diseases likely to disturb respiratory system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Comparison of two MBWN2 devices : &quot;EasyOne Pro Lab&quot; versus &quot;Exhalyzer D&quot;</intervention_name>
    <description>Healthy and Cystic Fibrosis participants will perform the same day MBWN2 tests in duplicate with each device.</description>
    <arm_group_label>Cystic fibrosis adults (CF)</arm_group_label>
    <arm_group_label>Healthy adults (HC)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        CF : primary care clinic HC : community sample
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cystic fibrosis diagnosis

        Exclusion Criteria:

          -  Respiratory infection within 3 weeks

          -  Chronically infected with methicillin-resistant Staphylococcus aureus or Burkholderia
             Cepacia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Lebecque, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Poncin, PhD student</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anne-Sophie Aubriot, PhD student</last_name>
    <role>Study Chair</role>
    <affiliation>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cliniques universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2015</study_first_submitted>
  <study_first_submitted_qc>February 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2015</study_first_posted>
  <last_update_submitted>July 29, 2015</last_update_submitted>
  <last_update_submitted_qc>July 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</investigator_affiliation>
    <investigator_full_name>Poncin</investigator_full_name>
    <investigator_title>Physiotherapist</investigator_title>
  </responsible_party>
  <keyword>Lung Clearance Index</keyword>
  <keyword>Cystic Fibrosis</keyword>
  <keyword>Multiple Breath Nitrogen Washout</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

